Ray Therapeutics: $125 Million Series B Raised For Vision Restoration Therapies
By Amit Chowdhry ● Today at 11:18 AM
Ray Therapeutics announced the closing of an upsized and oversubscribed $125 million Series B financing round to advance its vision-restoration treatments. The round was led by Janus Henderson Investors, with participation from new investors Adage Capital Management, Franklin Templeton, Invus, and Marshall Wace. Existing investors, including 4BIO Capital, Deerfield Management, MRL Ventures Fund, Norwest, Novo Holdings, and Platanus, also participated in the financing.